Human medicines European public assessment report (EPAR): Axura, memantine, Alzheimer Disease, Date of authorisation: 17/05/2002, Revision: 25, Status: Authorised
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):